ENS is trading at $6.45, down 4.7448% over 24 hours, and sits much closer to the $6.30 low than the $6.77 high of its daily range. This positioning, alongside the day’s decline, indicates near-term selling pressure, though the range alone does not establish whether that pressure will continue.

The moving-average picture is mixed but tilts bearish: price is above the 8-hour SMA at $6.40 and 13-hour SMA at $6.42, but below the 21-hour SMA at $6.47, 55-hour SMA at $6.69, and 144-hour SMA at $6.80. The two shortest averages provide limited evidence of short-term support, while the price’s position beneath the three longer hourly averages shows that it has not recovered those reference levels.

Momentum readings also lean weak without showing an extreme. The 1-hour RSI of 39 is below the midpoint and consistent with soft near-term momentum, while the 7-day RSI of 45 is closer to neutral; neither reading, on its own, signals an oversold condition.

Returns conflict across timeframes. ENS is down 7.3649% over seven days and 3.5406% over 14 days, supporting a bearish short-term reading, but it remains up 5.3079% over 30 days, indicating that the recent weakness follows a positive monthly performance rather than a uniformly declining set of returns.

The 24-hour volume is 14,947,755, and volume-to-market-cap is 5.48%. Without comparable or historical volume data, these figures cannot establish whether trading activity is unusually strong or whether the price decline has notable volume confirmation.

At $6.45, ENS is about 92% below its $83.40 all-time high from November 2021. That is useful historical context but does not by itself indicate future direction, and the supplied data do not identify a price level that should be treated as support or resistance.

Overall rating: Hold. The negative daily and weekly changes, price near the daily low, and position below three of five hourly moving averages argue against a Buy and show meaningful near-term weakness. However, the positive 30-day return, price slightly above the two shortest averages, and lack of an extreme RSI reading make the evidence less conclusive than a strong Sell signal; the balance supports waiting for clearer confirmation.